Bobak R. Azamian - 21 Mar 2023 Form 4 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Signature
/s/ Leonard M. Greenstein, Attorney-in-Fact
Issuer symbol
TARS
Transactions as of
21 Mar 2023
Transactions value $
-$26,669
Form type
4
Filing time
23 Mar 2023, 19:50:48 UTC
Previous filing
21 Mar 2023
Next filing
21 Apr 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARS Common Stock Sale -$8.75K -679 -6.33% $12.89 10K 21 Mar 2023 Direct F1
transaction TARS Common Stock Sale -$8.96K -709 -7.06% $12.64 9.33K 22 Mar 2023 Direct F1
transaction TARS Common Stock Sale -$8.95K -737 -7.9% $12.15 8.6K 23 Mar 2023 Direct F1
holding TARS Common Stock 1.08M 21 Mar 2023 By the Bobak Azamian Living Trust, established April 16, 2018 F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
F2 The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.